يعرض 1 - 20 نتائج من 66 نتيجة بحث عن '"Yeşil, Çınkır"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    مصطلحات موضوعية: Lung Cancer Patients, ALK

    وصف الملف: application/pdf

    Relation: Medicine (United States); Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Kılıçkap, S., Öztürk, A., Karadurmuş, N., Korkmaz, T., Yumuk, P. F., Çiçin, İ. . Erman, M. (2024). A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy. Medicine (United States), 103(21), E37972. http://dx.doi.org/10.1097/MD.0000000000037972; http://dx.doi.org/10.1097/MD.0000000000037972; https://hdl.handle.net/20.500.12511/12613; 103; 21; E37972; Q2; 001230616700060; 2-s2.0-85194219961; Q3

  3. 3
    Academic Journal

    وصف الملف: application/pdf

    Relation: BMC Cancer; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. . Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0; https://dx.doi.org/10.1186/s12885-024-11863-0; https://hdl.handle.net/20.500.12511/12264; 24; Q2; 001148300200002

  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
  8. 8
    Conference

    وصف الملف: application/pdf

    Relation: Journal of Thoracic Oncology; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; Kılıçkap, S., Demirci, U., Buğdaycı, F., Tural, D., Korkmaz, T., Paydaş, S. . Çiçin, İ. (2019). Lorlatinib in ALK- or ROS1-positive non-small cell lung cancer patients: Experience from an early access program in Turkey. Journal of Thoracic Oncology içinde (S558-S559. ss.). Elsevier Science. https://doi.org/10.1016/j.jtho.2019.08.1166; https://doi.org/10.1016/j.jtho.2019.08.1166; https://hdl.handle.net/20.500.12511/4670; 14; 10; S558; S559; Q1

  9. 9
  10. 10
    Academic Journal

    مصطلحات موضوعية: Lorlatinib, Real-World Data, ALK, ROS1

    وصف الملف: application/pdf

    Relation: Lung cancer; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Peled, N., Gillis, R., Kılıçkap, S., Froesch, P., Orlov, S., Filippova, E. . Roisman, L. C. (2020). Glass: Global lorlatinib for ALK(+) and ROS1(+) retrospective study: Real world data of 123 NSCLC patients. Lung cancer, 148, 48-54. https://dx.doi.org/10.1016/j.lungcan.2020.07.022; https://dx.doi.org/10.1016/j.lungcan.2020.07.022; https://hdl.handle.net/20.500.12511/5930; 148; 48; 54; Q1

  11. 11
  12. 12

    المساهمون: İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kilickap, Saadettin, AAP-3732-2021

    المصدر: Journal of Cancer Research and Clinical Oncology. 148:3547-3555

    وصف الملف: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
  20. 20
    Academic Journal